轮流 发表于 2025-3-23 11:46:06
http://reply.papertrans.cn/23/2209/220801/220801_11.pngHemiplegia 发表于 2025-3-23 16:42:29
http://reply.papertrans.cn/23/2209/220801/220801_12.png表主动 发表于 2025-3-23 19:32:22
Disorders of Phosphorous Homeostasis in CKD, patients with kidney disease are often hyperphosphatemic. Elevations in serum P. are associated with increased morbidity and mortality in patients with CKD, may hasten loss of residual renal function, and can cause secondary hyperparathyroidism. Unfortunately, current removal of P. with thrice week碎石头 发表于 2025-3-23 23:39:09
Pathogenesis and Management of Secondary Hyperparathyroidism,reduction in serum calcitriol levels, moderate decreases in ionized calcium, and reduced excretion of serum phosphorus contribute to the development of SHPT. Traditional approaches in the treatment of SHPT have focused on phosphorus control, through dietary phosphate restriction, calcium and non-calSTAT 发表于 2025-3-24 06:08:11
http://reply.papertrans.cn/23/2209/220801/220801_15.png流动才波动 发表于 2025-3-24 09:27:14
https://doi.org/10.1007/978-3-322-94140-4reduction in serum calcitriol levels, moderate decreases in ionized calcium, and reduced excretion of serum phosphorus contribute to the development of SHPT. Traditional approaches in the treatment of SHPT have focused on phosphorus control, through dietary phosphate restriction, calcium and non-calsynovitis 发表于 2025-3-24 13:23:04
http://reply.papertrans.cn/23/2209/220801/220801_17.pngConfidential 发表于 2025-3-24 17:39:15
http://image.papertrans.cn/c/image/220801.jpg注意 发表于 2025-3-24 20:54:18
https://doi.org/10.1007/978-0-387-33370-0absorption; age; calcium; diseases; hormone; kidney; management; metabolism; pathogenesis; patients; plasma; relicence 发表于 2025-3-25 00:51:06
978-1-4419-4122-0Springer-Verlag US 2006